Financial PerformanceFree cash flow jumped significantly, with management reiterating expectations for FCF approaching $300M this year, suggesting potential interest expense leverage could improve earnings next year.
Market GrowthThe contact lens market grew 7% in calendar Q2 per management and Cooper Companies took share again growing 10%.
Product LeadershipCooper believes the company's MiSight has right to win as the only FDA approved contacts for addressing progression of myopia.